Quarterly report pursuant to Section 13 or 15(d)

COMMON STOCK WARRANTS (Details Narrative)

v2.4.0.6
COMMON STOCK WARRANTS (Details Narrative) (USD $)
3 Months Ended 63 Months Ended 0 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Oct. 30, 2012
Oct. 30, 2012
Warrants
Oct. 24, 2012
Warrants
Jul. 17, 2012
Warrants
Apr. 10, 2012
Warrants
Dec. 15, 2009
Warrants
Dec. 31, 2012
Warrants
Sep. 07, 2012
Warrants
Jul. 11, 2012
Warrants
Jun. 28, 2012
Warrants
May 18, 2012
Warrants
Apr. 12, 2012
Warrants
Mar. 03, 2012
Warrants
Dec. 21, 2011
Warrants
Dec. 16, 2011
Warrants
Aug. 23, 2011
Warrants
Jul. 15, 2011
Warrants
Jun. 13, 2011
Warrants
May 12, 2011
Warrants
Dec. 30, 2010
Warrants
Jul. 23, 2010
Warrants
Apr. 09, 2010
Warrants
Jan. 15, 2010
Warrants
Dec. 04, 2009
Warrants
Nov. 09, 2009
Warrants
Oct. 09, 2009
Warrants
Sep. 30, 2009
Warrants
Jun. 03, 2009
Warrants
Mar. 20, 2009
Warrants
Exercise price, warrant       1.19   0.50 0.50 0.60 0.18   1.00 0.95 1.20 0.95 0.90 0.65 0.65 0.65 0.67 0.54 0.50 0.50 0.55 0.50 0.55 0.55 0.60 0.50 0.50 0.40 0.18 0.50
Proceeds from warrants exercised for cash $ 111,891    $ 4,019,451     $ 100,000                                                    
Exercise of awards, shares           200,000 (30,000) (43,392) (5,583,336)                                              
Extension of warrants, description         On October 30, 2012, the Company agreed to extend the term of the 11,985,367 common stock purchase warrants, expiring October 31, 2012, to April 30, 2013, subject to the warrant agreement, as amended. These amendments include removal of the cashless exercise provision and early termination of the extension period, at the sole discretion of the Company, in the event that the Company's common stock trades at or above $1.50 for 5 consecutive days. The warrants are exercisable at $1.19.                                                      
Extension of warrants, warrants extended       11,985,367                                                        
Warrants expense - vested warrants 167,966                                                              
Unamortized warrants expense 34,000   34,000                                                          
Intrinsic value of awards                   $ 11,300,000